Elevance Health Inc. (ELV)
Elevance Health Statistics
Share Statistics
Elevance Health has 227.35M shares outstanding. The number of shares has increased by -0.32% in one year.
Shares Outstanding | 227.35M |
Shares Change (YoY) | -0.32% |
Shares Change (QoQ) | 0.02% |
Owned by Institutions (%) | 88.39% |
Shares Floating | 226.9M |
Failed to Deliver (FTD) Shares | 39 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 3.63M, so 1.56% of the outstanding shares have been sold short.
Short Interest | 3.63M |
Short % of Shares Out | 1.56% |
Short % of Float | 1.57% |
Short Ratio (days to cover) | 1.87 |
Valuation Ratios
The PE ratio is 14.37 and the forward PE ratio is 10.2. Elevance Health's PEG ratio is -369.04.
PE Ratio | 14.37 |
Forward PE | 10.2 |
PS Ratio | 0.49 |
Forward PS | 0.4 |
PB Ratio | 2.08 |
P/FCF Ratio | 18.87 |
PEG Ratio | -369.04 |
Enterprise Valuation
Elevance Health Inc. has an Enterprise Value (EV) of 129.84B.
EV / Earnings | 21.71 |
EV / Sales | 0.73 |
EV / EBITDA | 14.28 |
EV / EBIT | 0.95 |
EV / FCF | 28.52 |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.76.
Current Ratio | 2.01 |
Quick Ratio | 2.01 |
Debt / Equity | 0.76 |
Total Debt / Capitalization | 43.05 |
Cash Flow / Debt | 0.19 |
Interest Coverage | 115.81 |
Financial Efficiency
Return on equity (ROE) is 0.14% and return on capital (ROIC) is 142.69%.
Return on Equity (ROE) | 0.14% |
Return on Assets (ROA) | 0.05% |
Return on Capital (ROIC) | 142.69% |
Revenue Per Employee | $1,696,833.01 |
Profits Per Employee | $57,389.64 |
Employee Count | 104,200 |
Asset Turnover | 1.51 |
Inventory Turnover | n/a |
Taxes
Income Tax | 1.93B |
Effective Tax Rate | 0.24 |
Stock Price Statistics
The stock price has increased by -16.72% in the last 52 weeks. The beta is 0.86, so Elevance Health's price volatility has been higher than the market average.
Beta | 0.86 |
52-Week Price Change | -16.72% |
50-Day Moving Average | 404.2 |
200-Day Moving Average | 457.92 |
Relative Strength Index (RSI) | 62.47 |
Average Volume (20 Days) | 1.63M |
Income Statement
In the last 12 months, Elevance Health had revenue of 176.81B and earned 5.98B in profits. Earnings per share was 25.68.
Revenue | 176.81B |
Gross Profit | 157.06B |
Operating Income | 137.24B |
Net Income | 5.98B |
EBITDA | 9.09B |
EBIT | 137.24B |
Earnings Per Share (EPS) | 25.68 |
Balance Sheet
The company has 8.29B in cash and 31.23B in debt, giving a net cash position of -22.94B.
Cash & Cash Equivalents | 8.29B |
Total Debt | 31.23B |
Net Cash | -22.94B |
Retained Earnings | 33.55B |
Total Assets | 116.89B |
Working Capital | 26.36B |
Cash Flow
In the last 12 months, operating cash flow was 5.81B and capital expenditures -1.26B, giving a free cash flow of 4.55B.
Operating Cash Flow | 5.81B |
Capital Expenditures | -1.26B |
Free Cash Flow | 4.55B |
FCF Per Share | 19.55 |
Margins
Gross margin is 88.83%, with operating and profit margins of 77.62% and 3.38%.
Gross Margin | 88.83% |
Operating Margin | 77.62% |
Pretax Margin | 4.47% |
Profit Margin | 3.38% |
EBITDA Margin | 5.14% |
EBIT Margin | 77.62% |
FCF Margin | 2.57% |
Dividends & Yields
ELV pays an annual dividend of $6.6, which amounts to a dividend yield of 1.61%.
Dividend Per Share | $6.60 |
Dividend Yield | 1.61% |
Dividend Growth (YoY) | 4.91% |
Payout Ratio | 25.72% |
Earnings Yield | 5.95% |
FCF Yield | 4.64% |
Analyst Forecast
The average price target for ELV is $512, which is 18.6% higher than the current price. The consensus rating is "Buy".
Price Target | $512 |
Price Target Difference | 18.6% |
Analyst Consensus | Buy |
Analyst Count | 15 |
Stock Splits
The last stock split was on Jun 1, 2005. It was a forward split with a ratio of 2:1.
Last Split Date | Jun 1, 2005 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 3.25 |
Piotroski F-Score | 5 |